Search

Simple Summary: The intestinal tract is one of the most important barriers in an organism. Cyclophosphamide can lead to the destruction of the structural integrity of the intestinal barrier, causing immunosuppression, oxidative stress, and microbiota disorders. Conversely, cow placenta extract can improve the immunity and antioxidant power of the organism, etc. Therefore, it is important to investigate the protective effects of cow placenta extract on the intestinal barrier, intestinal immune function, and intestinal microbiota caused by cyclophosphamide to provide a new approach for its clinical application in the treatment of intestinal injury caused by immunosuppression. Immunosuppression undermines intestinal barrier integrity. Cow placenta extract (CPE) primarily consists of active peptides with immunomodulatory and antioxidant effects. This study aimed to examine the preventive effect of CPE against intestinal damage induced by cyclophosphamide (Cy) in immunosuppressed mice. Thirty-six mice were randomly allocated into three groups: control group (C), model group (M), and treatment group (CPE). The mice in the CPE group were provided with 1500 mg/kg/day of CPE via gavage. In the last 3 days, mice in the groups M and CPE received intraperitoneal injections of 80 mg/kg/day of Cy. The results showed that CPE improved intestinal barrier function by decreasing serum d-Lactate (D-LA) levels and diamine oxidase (DAO) activity, while elevating the relative expression of Occludin, zonula occludens-1 (ZO-1), and mucin-2 (MUC-2) mRNA. Additionally, CPE improved the immune organ index and elevated the levels of secretory immunoglobulin A (sIgA), superoxide dismutase (SOD), interleukin-1beta (IL-1β), interleukin-4 (IL-4), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) in the intestine, thereby enhancing intestinal mucosal immune function. Furthermore, CPE improved the diversity of intestinal microbiota and increased the abundance of Candidatus_Saccharimonas, Psychrobacter, and Enterorhabdus, which promoted the proper functioning of the intestines. These findings suggest that CPE effectively ameliorates Cy-induced intestinal damage by enhancing the intestinal barrier, improving immune function, and restoring intestinal microbiota. [ABSTRACT FROM AUTHOR]

Because of the overbearing low temperature, cold areas increase the morbidity and mortality of chronic non-communicable diseases (chronic diseases) in exposed populations. With the growth of the aging population and the superposition of lifestyle risk factors, the number of people with chronic diseases in cold areas is climbing, and the family and social burdens are rising. These health-threatening circumstances in the cold areas render the general practitioners to face serious challenges and difficulties in the community management of chronic diseases. This paper summarizes the current situation of chronic disease management in cold areas and explores the relevant management models so as to provide a useful reference for regional health construction, graded diagnosis and treatment, and prevention and control of chronic diseases in China.

Our preliminary study identified dairy cow placenta extract (CPE) as a mixture of peptides with potent antioxidant activity both in vivo and in vitro. However, the specific antioxidant peptides (AOPs) responsible for this activity were not yet identified. In the current study, we employed virtual screening and chromatography techniques to isolate two peptides, ANNGKQWAEVF (CP1) and QPGLPGPAG (CP2), from CPE. These peptides were found to be less stable under extreme conditions such as high temperature, strong acid, strong alkali, and simulated digestive conditions. Nevertheless, under normal physiological conditions, both CP1 and CP2 exhibited significant antioxidant properties, including free-radical scavenging, metal chelating, and the inhibition of lipid peroxidation. They also up-regulated the activities of intracellular antioxidant enzymes in response to hydrogen-peroxide-induced oxidative stress, resulting in reduced MDA levels, a decreased expression of the Keap1 gene and protein, and increased levels of the Nrf2 and HO-1 genes and proteins. Furthermore, CP1 demonstrated superior antioxidant activity compared to CP2. These findings suggest that CP1 and CP2 hold potential for mitigating oxidative stress in vitro and highlight the efficacy of virtual screening as a method for isolating AOPs within CPE. [ABSTRACT FROM AUTHOR]

Plant Extracts (PE) are natural substances extracted from plants, rich in various bioactive components. Exploring the molecular mechanisms and interactions involved in the vascular protective effects of PE is beneficial for the development of further strategies to protect aging blood vessels. For this review, the content was obtained from scientific databases such as PubMed, China National Knowledge Infrastructure (CNKI), and Google Scholar up to July 2024, using the search terms "Plant extracts", "oxidative stress", "vascular aging", "endothelial dysfunction", "ROS", and "inflammation". This review highlighted the effects of PE in protecting aging blood vessels. Through pathways such as scavenging reactive oxygen species, activating antioxidant signaling pathways, enhancing respiratory chain complex activity, inhibiting mitochondrial-reactive oxygen species generation, improving nitric oxide bioavailability, downregulating the secretion of inflammatory factors, and activating sirtuins 1 and Nrf2 signaling pathways, it can improve vascular structural and functional changes caused by age-related oxidative stress, mitochondrial dysfunction, and inflammation due to aging, thereby reducing the incidence of age-related cardiovascular diseases. [ABSTRACT FROM AUTHOR]

Single-frequency (SF) lasers in the visible spectral region are usually obtained through an indirect method, i.e., frequency doubling of near-infrared SF lasers. In this work, we report on the direct generation of a high-power continuous-wave (CW) SF laser in red based on a diode-pumped Pr:LiYF 4 (YLF) ring cavity technology. A maximum output power is scaled to 3.98 W at 640 nm with a linewidth of about 17.2 MHz and a power stability of 0.6%. Moreover, by inserting a LBO crystal into the ring cavity for intracavity frequency doubling of the 640 nm SF laser, we have also successfully demonstrated an ultraviolet (UV) SF laser at 320 nm, for the first time to the best of our knowledge, with a maximum power of 670 mW. This work provides a promising route for the development of simple, compact, and high-power SF lasers operating in visible and UV spectral regions.

Using a CZ-grown a-cut Pr:YLF crystal as laser gain medium after processing it into crystal fiber, we have demonstrated real Pr 3+ -doped single-crystal fiber lasers for the first time to the best of our knowledge. This Pr 3+ crystal fiber has absorbed up to 20.4 W of pump power, which is the highest absorbed power among Pr 3+ lasers. For two representative laser emissions at about 639 nm and 607 nm, we have achieved maximum output powers of 5.45 W and 3.04 W, respectively. Output powers of the two lasers show very good linearities, which indicate that the present output powers are only limited by the available pump power. Both laser emissions have exhibited near diffraction-limited beam qualities. This proposal has provided a good and feasible route for the development of compact, high-power, and high-brightness all-solid-state Pr 3+ visible lasers via crystal fiber.